title: Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification.
abstract: BACKGROUND
  Left ventricular hypertrophy (LVH) is an important predictor of cardiovascular risk, and its detection contributes to risk stratification. The aims of the present study were to estimate the prevalence of echocardiographic LVH and to evaluate the influence of echocardiography (ECHO) on cardiovascular risk stratification in hypertensive patients presenting in primary care.
  
  
  METHODS
  In this cross-sectional study, 250 patients recently diagnosed with mild hypertension underwent clinical evaluation including electrocardiography (ECG), microalbuminuria measurement, 24-h blood pressure monitoring and ECHO. Level of cardiovascular risk was stratified, initially using routine procedures including ECG to assess target organ damage and then again after detection of LVH by ECHO.
  
  
  RESULTS
  The frequency of echocardiographic LVH was 32%, substantially higher than that detected by ECG (9%). Initial cardiovascular risk stratification yielded the following results: 30% low risk, 49% medium risk, 16% high risk, and 5% very high risk subjects. The detection of LVH by ECHO provoked a significant change in the risk strata distribution, particularly in those patients initially classified as being at medium risk. In this group, 40% of subjects were reclassified as high risk subjects according to ECHO information. The new classification was as follows: 23% low risk, 30% medium risk, 42% high risk, and 5% very high risk subjects.
  
  
  CONCLUSIONS
  A substantial proportion of mildly hypertensive patients presenting in primary care have LVH determined by ECHO. Our results suggest that this procedure could significantly improve cardiovascular risk stratification in those patients with multiple risk factors, but no evidence of target organ damage by routine investigations.
authors.affiliation: Primary Care and Hospital Research Unit, Hospital La Paz, Universidad Autónoma de Madrid, Madrid, Spain. jrvillagrasa@terra.es
authors.forename: María A
authors.initials: MA
authors.lastname: Martinez
authors.forename: Teresa
authors.initials: T
authors.lastname: Sancho
authors.forename: Eduardo
authors.initials: E
authors.lastname: Armada
authors.forename: José M
authors.initials: JM
authors.lastname: Rubio
authors.forename: José L
authors.initials: JL
authors.lastname: Antón
authors.forename: Alberto
authors.initials: A
authors.lastname: Torre
authors.forename: Javier
authors.initials: J
authors.lastname: Palau
authors.forename: Paloma
authors.initials: P
authors.lastname: Seguido
authors.forename: Jaime
authors.initials: J
authors.lastname: Gallo
authors.forename: Isabel
authors.initials: I
authors.lastname: Saenz
authors.forename: Enrique
authors.initials: E
authors.lastname: Polo
authors.forename: Rosa
authors.initials: R
authors.lastname: Torres
authors.forename: José
authors.initials: J
authors.lastname: Oliver
authors.forename: Juan G
authors.initials: JG
authors.lastname: Puig
mesh_terms: D000419:Albuminuria; D018660:Blood Pressure Monitoring, Ambulatory; D003430:Cross-Sectional Studies; D004452:Echocardiography; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications*; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010808:Physical Examination; D015995:Prevalence; D011320:Primary Health Care; D018570:Risk Assessment